|
|
 |
|
| | |
| | | | | |
gene
|
|
PR:000004911 |
complement component C9
|
C9
|
"A protein that is a translation product of the human C9 gene or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:P02748 |
complement component C9 (human)
|
hC9
|
"A complement component C9 that is encoded in the genome of human." [PRO:DNx, UniProtKB:P02748]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000046536 |
complement component C9, signal peptide removed form (human)
|
hC9/SigPep-
|
"A complement component C9 (human) that has had the signal peptide removed. UniProtKB:P02748, 22-559." [PRO:DNx, Reactome:R-HSA-173717]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052740 |
complement component C9 N-glycosylated 1 (human)
|
hC9/NGlyco:1
|
"A complement component C9 (human) that has been N-glycosylated at the residue equivalent to Asn-277 of the amino acid sequence represented by UniProtKB:P02748-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P02748-1, Asn-277, MOD:00160~GNO:G00912UN." [GlyGen:P02748-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052741 |
complement component C9 N-glycosylated 2 (human)
|
hC9/NGlyco:2
|
"A complement component C9 (human) that has been N-glycosylated at the residue equivalent to Asn-415 of the amino acid sequence represented by UniProtKB:P02748-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P02748-1, Asn-415, MOD:00160~GNO:G00912UN." [GlyGen:P02748-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052742 |
complement component C9 O-glycosylated 1 (human)
|
hC9/OGlyco:1
|
"A complement component C9 (human) that has been O-glycosylated at the residue equivalent to Ser-26 of the amino acid sequence represented by UniProtKB:P02748-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P02748-1, Ser-26, MOD:00002~GNO:G58001LT." [GlyGen:P02748-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052743 |
complement component C9 O-glycosylated 2 (human)
|
hC9/OGlyco:2
|
"A complement component C9 (human) that has been O-glycosylated at the residue equivalent to Thr-24 of the amino acid sequence represented by UniProtKB:P02748-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02748-1, Thr-24, MOD:00005~GNO:G43417UB." [GlyGen:P02748-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052744 |
complement component C9 O-glycosylated 3 (human)
|
hC9/OGlyco:3
|
"A complement component C9 (human) that has been O-glycosylated at the residue equivalent to Thr-258 of the amino acid sequence represented by UniProtKB:P02748-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02748-1, Thr-258, MOD:00005~GNO:G29068FM." [GlyGen:P02748-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052745 |
complement component C9 O-glycosylated 4 (human)
|
hC9/OGlyco:4
|
"A complement component C9 (human) that has been O-glycosylated at the residue equivalent to Thr-258 of the amino acid sequence represented by UniProtKB:P02748-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02748-1, Thr-258, MOD:00005~GNO:G43417UB." [GlyGen:P02748-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052746 |
complement component C9 O-glycosylated 5 (human)
|
hC9/OGlyco:5
|
"A complement component C9 (human) that has been O-glycosylated at the residue equivalent to Thr-32 of the amino acid sequence represented by UniProtKB:P02748-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02748-1, Thr-32, MOD:00005~GNO:G29068FM." [GlyGen:P02748-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052747 |
complement component C9 O-glycosylated 6 (human)
|
hC9/OGlyco:6
|
"A complement component C9 (human) that has been O-glycosylated at the residue equivalent to Thr-32 of the amino acid sequence represented by UniProtKB:P02748-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02748-1, Thr-32, MOD:00005~GNO:G43417UB." [GlyGen:P02748-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:P06683 |
complement component C9 (mouse)
|
mC9
|
"A complement component C9 that is encoded in the genome of mouse." [OMA:P06683, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:Q62930 |
complement component C9 (rat)
|
rC9
|
"A complement component C9 that is encoded in the genome of rat." [OMA:Q62930, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
modification
|
|
PR:000019198 |
complement component C9, signal peptide removed form
|
C9/SigPep-
|
"A complement component C9 that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000046536 |
complement component C9, signal peptide removed form (human)
|
hC9/SigPep-
|
"A complement component C9 (human) that has had the signal peptide removed. UniProtKB:P02748, 22-559." [PRO:DNx, Reactome:R-HSA-173717]
|
|
|
|
|
|
|
| | | | |
| | | |
modification
|
|
PR:000019199 |
complement component C9 proteolytic cleavage product
|
C9/ClvPrd
|
"A complement component C9 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
